Progyny, Inc. Stock Price, News & Analysis

Progyny (Nasdaq: PGNY), a global leader in women's health and family building, has scheduled its first quarter 2025 financial results announcement for Thursday, May 8, 2025, after market close. The company will host a conference call at 4:45 p.m. ET (1:45 p.m. PT) to discuss the results.

Participants can join the call using the following details:

• US participants: 1.866.825.7331
• International participants: 1.973.413.6106
• Passcode: 265484

Progyny (NASDAQ: PGNY), a leader in women's health and family building, has announced two key executive appointments to support its growth and innovation strategy. Melissa Cummings joins as the company's first Chief Operating Officer (COO) and Geoffrey Clapp as its first Chief Product Officer (CPO).

Cummings brings 30 years of healthcare experience, most recently serving as Executive Vice President and Chief Customer Officer at Blue Cross & Blue Shield of Rhode Island. Clapp, with over two decades in healthcare technology, previously held the position of Senior Vice President and Head of Strategy at Optum Health Solutions.

The appointments come as Progyny experiences significant growth, now serving more than 530 employers with 6.7 million contracted lives. The company has expanded its services to include Parent and Child Well-being programs and doula support, positioning itself as a comprehensive solution for reproductive health care.

Progyny (Nasdaq: PGNY), a leader in women's health and family building solutions, announces multiple events for National Infertility Awareness Week (NIAW) and Canadian Fertility Awareness Week (CFAW) from April 20-26, 2025.

Key events include:

• April 21: Nasdaq Stock Market Opening Bell ceremony and Empire State Building lighting in orange
• April 22: 'Infertility Unfiltered' Panel Event in New York and 'Light the Night' Event in Chicago
• April 24: CN Tower lighting in green for CFAW in Toronto

The campaign features advocates Jessi and Alessio Pasini, and Demi and Tom Schweers sharing their fertility journeys. Progyny is partnering with RESOLVE: The National Infertility Association and Fertility Matters Canada to raise awareness about fertility care accessibility and reduce stigma associated with infertility, which affects one in six people trying to conceive.

Progyny (NASDAQ: PGNY) and The Broken Brown Egg have announced their fourth annual Awareness, Hope, and Activism (AHA) Grant for 2025, aimed at supporting BIPOC individuals and couples in family building. The partnership addresses systemic barriers including financial obstacles, health disparities, and social stigmas in fertility care.

Grant recipients will receive comprehensive support including:

• Financial assistance for fertility treatments
• Enhanced medication support through Alto Pharmacy with same-day delivery options
• Unlimited access to a dedicated Progyny Patient Care Advocate
• Clinical education and emotional support throughout their journey

The grant application period runs from April 8 to May 12, 2025, open to U.S. citizens and legal residents aged 18-45. Winners will be selected by a panel of BIPOC infertility advocates and physicians, with announcements scheduled for May 19.

Progyny (NASDAQ: PGNY) announces the expansion of its maternal health services by introducing doula support, both in-person and virtual. The company has partnered with Pacify, a leading maternity care solutions provider, to enhance its comprehensive maternal offerings.

The new doula services aim to address pregnancy, childbirth, and perinatal conditions, which represent a significant portion of employer health spending in the U.S. Members will be matched with specialty-trained, certified doulas based on their care needs and demographic preferences.

Research indicates that doula support may help:

• Reduce C-section rates
• Lower NICU complications
• Decrease maternal health barriers
• Improve overall birthing experience

The service is integrated into Progyny's Pregnancy and Postpartum program, offering support throughout the pregnancy journey, including prenatal care, labor support, lactation assistance, postpartum care, and miscarriage support.

Progyny (NASDAQ: PGNY) has launched its new Parent and Child Well-being offering, expanding its family building solutions portfolio. The program aims to support working parents and caregivers with comprehensive services addressing return-to-work challenges and emotional health support.

The offering comes as statistics show nearly 40% of the U.S. workforce are parents with children under 18, with 48% reporting overwhelming daily stress. The program features:

• Personalized support from licensed clinical social workers
• Benefit navigation assistance for leave planning and paperwork
• Digital tools including educational content and webinars
• Return-to-work transition support

The service is designed to enhance job satisfaction and retention while providing continuous support from preconception through early childhood development. The program is available to employers and health plans.

Progyny (Nasdaq: PGNY), a leader in fertility, family building, and women's health benefits solutions, has announced its participation in three major investor conferences in March 2025.

The company's schedule includes:

• A fireside chat at the Leerink Partners Global Healthcare Conference in Miami on March 10, 2025, at 11:20 a.m. ET
• Meetings at the Barclays 27th Annual Global Healthcare Conference in Miami on March 11, 2025
• A virtual fireside chat with CEO Pete Anevski at the KeyBanc Capital Markets Healthcare Forum on March 19, 2025, at 2:15 p.m. ET

Live audiocasts and replays of the fireside chats will be accessible through Progyny's investor relations website at investors.progyny.com.

Progyny (NASDAQ: PGNY) reported Q4 2024 financial results with revenue of $298.4 million, up 10.6% year-over-year. The fertility benefits company generated quarterly operating cash flow of $52.2 million.

Key Q4 metrics include: fertility benefit services revenue of $187.5M (+9%), pharmacy benefit services revenue of $111.0M (+13%), gross profit of $63.4M (+11%), and net income of $10.5M. The company ended 2024 with 473 clients, up from 392 in 2023.

For full-year 2024, Progyny achieved revenue of $1.17B (+7.2%), net income of $54.3M, and Adjusted EBITDA of $198.8M. The company issued 2025 guidance projecting revenue between $1.175B-$1.225B (+1-5%) and expects to serve over 530 clients representing approximately 6.7 million covered lives.

Progyny (Nasdaq: PGNY), a fertility, family building, and women's health benefits solution provider, has scheduled its Q4 and Full Year 2024 financial results announcement for February 27, 2025, after market close. The company will host a conference call at 4:45 p.m. ET, accessible to U.S. participants at 1.866.825.7331 and international participants at 1.973.413.6106 (passcode: 265484).

An audio replay will be available until March 6, 2025, and can be accessed at 1.800.332.6854 (U.S.) or 1.973.528.0005 (international). A live webcast and recording will be available on the company's investor relations website.